ArticleCancers2022

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited.

Markus Diefenhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.